Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
37 results about "Pericardial edema" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Pericardial effusion (fluid around the heart) is an abnormal accumulation of fluid in the pericardial cavity. Because of the limited amount of space in the pericardial cavity, fluid accumulation leads to an increased intrapericardial pressure which can negatively affect heart function.
Implantable fluid management system for the removal of excess fluid
InactiveUS20050273034A1Increased risk of infectionAvoid difficultyWound drainsMedical devicesHydrocephalusPulmonary edema
An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
Owner:SEQUANA MEDICAL NV
Implantable fluid management system for the removal of excess fluid
ActiveUS20050096582A1Increased risk of infectionAvoid difficultyWound drainsMedical devicesHydrocephalusPulmonary edema
An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.
Owner:SEQUANA MEDICAL NV
Apparatus and methods for treating intracorporeal fluid accumulation
ActiveUS20120209165A1Reduced risk of cloggingLimit its operationDrug and medicationsWound drainsTransceiverFluid management
A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.
Owner:SEQUANA MEDICAL NV
Apparatus and methods for treating intracorporeal fluid accumulation
ActiveUS9039652B2Reduced risk of cloggingLittle patient involvementDrug and medicationsWound drainsTransceiverFluid management
A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.
Owner:SEQUANA MEDICAL NV
Implantable fluid management system having clog resistant catheters, and methods of using same
ActiveUS20180056050A1Reduce cloggingReduce potential cloggingWound drainsMedical devicesFluid managementCvd risk
A fluid management system for moving bodily fluid accumulated due to ascites, pleural effusion or pericardial effusion is provided including an implantable pump coupled to an inflow catheter, an outflow catheter, and optionally an anti-clog catheter. The fluid management system facilitates removal of fluid from a body region, such as the peritoneum, pleural cavity or pericardial sac, where drainage is desired to another body region, such as the urinary bladder or the peritoneal cavity. The system includes clog resistant mechanisms such as clog resistant catheters and / or programmed routines for cycling fluid through inlet catheters in predetermined time intervals and / or responsive to sensed conditions to minimize the risk that inlet catheters become clogged due to, for example, tissue ingrowth and / or solid objects within accumulated fluid.
Owner:SEQUANA MEDICAL NV
Apparatus and methods for noninvasive monitoring of cancerous cells
ActiveUS9675327B2Reduced risk of cloggingLimit its operationSurgeryVaccination/ovulation diagnosticsCancer cellAscites
A system for noninvasively monitoring cancerous cells within bodily fluid accumulated due to ascites, pleural effusion or pericardial effusion is provided including an implantable pump having control circuitry; a charging and communication system configured to periodically charge and communicate with the implantable pump to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable pump and charging and communication system. The implantable pump is configured to move fluid containing cancerous cells from a body cavity to the bladder such that the fluid may be excreted during urination, collected and analyzed with an analysis station to assess progress of the cancer or efficacy of a cancer treatment program.
Owner:SEQUANA MEDICAL AG
Group I type 4 aviadenovirus strain WZ and application of strain WZ
ActiveCN106754754AImprove featuresImproving immunogenicitySsRNA viruses negative-senseSsRNA viruses positive-senseViral VaccineAvian adenovirus
The invention discloses a group I type 4 aviadenovirus strain WZ. The strain has a preservation number of China Center for Type Culture Collection (CCTCC) No: V201662, is named as group I type 4 aviadenovirus strain WZ in a classified way, and is preserved in December 14, 2016; a group I type 4 viral vaccine of the aviadenovirus is prepared from the inactivated group I type 4 aviadenovirus strain which is taken as an active ingredient; the invention also provides application of the group I type 4 aviadenovirus strain WZ in preparation of an agar gel precipitating antigen, a hemagglutination inhibition (HI) antigen and positive serum antigen reagent which are used for diagnosing the group I type 4 virus of the aviadenovirus, and preparation of egg yolk antibody and antiserum which are used for treating the group I type 4 virus of the aviadenovirus. After the vaccine prepared by using the group I type 4 aviadenovirus strain is used for immunizing, the toxin attacking protection rate for the group I type 4 aviadenovirus strain WZ reaches 90-100%. As a vaccine strain with good manufacturing effect, the group I type 4 aviadenovirus strain WZ can be used for preventing avian inclusion body hepatitis and pericardial effusion syndrome, and also can be used for virus identification and epidemiological investigation.
Owner:HENAN AGRICULTURAL UNIVERSITY
Use of autologous sediment from fluid aspirates as vehicles for drug delivery
InactiveUS20070059372A1Minimize any inflammatory responsePowder deliveryMammal material medical ingredientsGene vectorCytokine
A method of using fluid aspirates as vehicles for drug delivery by collecting a fluid aspirate such as synovial joint effusion, pleural effusion, pericardial effusion, or ascites from a patient and centrifuging the fluid aspirate to provide a supernatant and a sedimented material. The sedimented material can optionally be further purified. One or more factors such as cytokines, bone morphogenetic proteins (BMPs), pharmaceutical drugs and gene vectors are added to the sedimented material or supernatant, optionally also including a biologically compatible medium such as a bioabsorbable sponge, so as to provide a vehicle for the one or more factors for reintroducion into the patient.
Owner:JOHNSON LANNY L
Triad trocar device and method for deep tissue puncture
PendingCN110339435AIncreased sensitivityAvoid damageInfusion syringesMedical devicesClinical prognosisTrocar device
The invention provides a triad trocar device for deep tissue puncture. The triad trocar device comprises a thick puncture needle, a puncture cannula and a fine puncture needle; in the puncture process, when shallow tissue is punctured, the tips of the thick puncture needle, the puncture cannula and the fine puncture needle are aligned; when deep tissue is punctured, the puncture cannula and the fine puncture needle extend out of the first end of the thick puncture needle and pierce into the deep tissue together, then the fine puncture needle is withdrawn, and a channel is established between the deep tissue and the exterior of the body of a subject through the puncture cannula. By means of the puncturing device and method, important tissue organ damage can be reduced when the deep tissue is punctured, the sensitivity of the deep tissue during puncturing is increased, and the success rate of puncturing is improved, so that clinical prognosis is improved, and the device and method can beapplied to clinical practice such as pericardial effusion puncture drainage and subclavicular vein puncture catheterization, and have high clinical application value.
Owner:GENERAL HOSPITAL OF PLA +1
Application of taxol in prevention and treatment of pericardial effusion of chickens
InactiveCN106420690AEffective controlImprove conversion rateOrganic active ingredientsAccessory food factorsFeed additiveBroiler
The invention belongs to the technical field of disease prevention of agricultural breeding, and particularly relates to application of taxol in prevention and treatment of pericardial effusion of chickens. The taxol is used for a feed additive for preventing and treating the pericardial effusion of the chickens. Compared with the prior art, the application of taxol in prevention and treatment of pericardial effusion of chickens has the advantages that new application of the taxol is provided, and the taxol is used for preventing and treating the pericardial effusion of the chickens, and plays an important role in large-scale breeding of broilers; and the taxol, evening primrose oil and tylosin are used in feedstuff in a matched manner, and the pericardial effusion of the chickens can be effectively prevented and treated in a growth stage of the chickens, meanwhile, immunity of the organism can further be improved, and high feed conversion ratio and high production performance can be kept.
Owner:ANHUI HUAAO BIOTECH
Group I avian adenovirus type 8 strain and application thereof
ActiveCN109207437AImprove securityImprove protectionViral antigen ingredientsDigestive systemDiseaseInclusion bodies
The invention relates to the technical field of veterinary biological products, in particular to a group I avian adenovirus type 8 strain and application thereof. The group I avian adenovirus type 8 strain ZMYTAV-8 strain, with an accession number of CGMCC No. 14297 has the characteristics of high toxin production and good immunogenicity. The strain can effectively prevent chicken inclusion body hepatitis caused by serum avian adenovirus type 8. Therefore, the invention also provides application of the avian adenovirus type 8 strain ZMYTAV-8 in the preparation of drugs for the prevention of inclusion body hepatitis. Further, the present invention provides a bivalent inactivated vaccine of avian adenovirus serotype 4, serotype 8 for the prevention of pericardial effusion-hepatitis syndromeand inclusion body hepatitis. The vaccine has good immunogenicity and can prevent avian diseases caused by adenovirus, such as inclusion body hepatitis and pericardial effusion-hepatitis syndrome, which are popular in recent years. The vaccine has 100% protection rate against local isolates, and has high safety, rapid antibody production and stable efficacy.
Owner:乾元浩生物股份有限公司
Pain-alleviating traditional Chinese medicine composition and application thereof
The invention discloses a pain-alleviating traditional Chinese medicine composition and application thereof. The pain-alleviating traditional Chinese medicine composition is prepared from the following medicinal materials in percentages by weight: 10 to 30 percent of garden balsam, 10 to 30 percent of spreading hedyotis, 5 to 20 percent of ginseng, 5 to 20 percent of radix astragali and 1 to 5 percent of pearl powder. By an experiment, the applicant discovers that the toxic and side effects of the traditional Chinese medicine composition described by the invention are little, the total effective rate of the traditional Chinese medicine composition in alleviating cancerous pain is 100 percent, the complete remission rate in controlling cancerous pleural effusion, pericardial effusion and ascites reaches 94 percent, and the effective rate reaches 98 percent; the traditional Chinese medicine composition also has a remarkable effect in controlling the growth of tumors; the traditional Chinese medicine composition has a strong inhibition effect on human erythroleukemia cells.
Owner:刘宇清
General purpose type chest cavity indwelling drainage tube
The invention discloses a universal thoracic retention drainage tube, which comprises a double-chamber duct with flexibility and plasticity, wherein one chamber is a washing chamber, the other chamber is a drainage chamber, and the section of the washing chamber is smaller than the section of the drainage chamber; the front end of the double-chamber duct is processed into a circle shaped leading-in part, while the rear end is provided with a washing horn mouth communicated with the washing chamber and a drainage horn mouth communicated with the drainage chamber; and the inner side of the circle of the leading-in part is provided with a drainage hole communicated with the drainage chamber, while the outer side is provided with a washing hole communicated with the washing chamber. The universal thoracic retention drainage tube is provided with the drainage chamber and the washing chamber simultaneously and can simultaneously perform drainage and washing; the drainage chamber is large and not easy to block, so the drainage is more complete; a bending head design avoids damaging viscera and reduces irritant indisposition; and the universal thoracic retention drainage tube has wide application range, is suitable for treating pleural effusion, pericardial effusion and pyothorax, has low cost and can repeatedly wash and drain after once posting.
Owner:薛武
Use of autologous sediment from fluid aspirates as vehicles for drug delivery
InactiveUS7927630B2Minimize any inflammatory responsePharmaceutical delivery mechanismMammal material medical ingredientsGene vectorCytokine
A method of using fluid aspirates as vehicles for drug delivery by collecting a fluid aspirate such as synovial joint effusion, pleural effusion, pericardial effusion, or ascites from a patient and centrifuging the fluid aspirate to provide a supernatant and a sedimented material. The sedimented material can optionally be further purified. One or more factors such as cytokines, bone morphogenetic proteins (BMPs), pharmaceutical drugs and gene vectors are added to the sedimented material or supernatant, optionally also including a biologically compatible medium such as a bioabsorbable sponge, so as to provide a vehicle for the one or more factors for reintroducion into the patient.
Owner:JOHNSON LANNY L
Method for rapid and direct identification of microbial pathogen from positive culture sterile body fluids using mass spectrometry
InactiveUS20190293646A1Accurate mass spectrometryShort timeMicrobiological testing/measurementBiological testingClinical settingsLow speed
The invention provides methods for rapid isolation of microorganisms from positive culture sterile body fluids, including blood, cerebrospinal fluid (CSF), pleural fluid, ascitic fluid, pericardial effusion, joint cavity fluid, vitreous fluid, and amniotic fluid for mass spectrometry identification. Whenever the subject of blood culture is discussed, the intended sample used is always related to blood sample. However, it is also necessary to be aware that other than the blood sample, sterile fluids can also be inoculated as samples for blood culture testing. Among the sterile fluids that are commonly known are CSF, pleural fluid, ascitic fluid, pericardial effusion, joint cavity fluid, vitreous fluid, amniotic fluid etc. The methods involve combining micro-volume positive blood culture sample with detergent solution to lyse human blood cells, then isolating the microorganism by differential centrifugation process that first removes interfering substances such as charcoal (when present), resins and human blood cellular debris through a low speed centrifugation, then isolates the microorganisms in the sample supernatant through a fast centrifugation. The methods not only apply to regular blood culture media but also apply to antimicrobial removal containing media such as resin containing BD BACTEC™ Plus-Aerobic media and charcoal-containing Biomerieux BacT / Alert® FA media. In addition, the methods can isolate a variety of Gram-positive bacteria, Gram-negative bacteria, and yeast in clinical settings. The isolated microorganism(s) from positive blood culture can be used for multiple downstream analyses, including identification of the microorganism(s) by mass spectrometry, phonotypical, or molecular identification methods.
Owner:FENG LIPING
Closure device
The invention belongs to the technical field of medical equipment, and particularly relates to a closure device. The closure device comprises a sealing part and a fixing part, the fixing part comprises a plurality of supporting rods and at least one anchor thorn arranged on at least one supporting rod, a first end of each anchor thorn is fixed to the corresponding supporting rod, a second end of each anchor thorn faces the outside of the fixing part, wherein at least one anchor thorn is provided with at least one limiting piece, and the outer diameter of the part, located between the second end and the limiting piece, of the anchor thorn is smaller than that of the limiting piece. According to the closure device of the invention, at least one limiting piece is arranged on at least one anchor thorn, and the outer diameter of the part, located between the second end and the limiting piece, of the anchor thorn is smaller than that of the limiting piece, when the anchor thorn pierces the inner wall of the left auricle, the limiting piece on the anchor thorn can effectively limit the piercing depth of the anchor thorn, so that pericardial effusion and other problems caused by the situation that the anchor thorn pierces through the inner wall of the left auricle due to the excessively high piercing depth of the anchor thorn are solved, and the possibility of medical negligence is reduced.
Owner:LIFETECH SCIENTIFIC (SHENZHEN) CO LTD
Pericardial effusion assisted drainage device
InactiveCN109602962APain reliefReduce workloadMedical devicesIntravenous devicesAssistive device/technologyEffusion
The present invention relates to the technical field of medical auxiliary devices and particularly relates to a pericardial effusion auxiliary drainage device. The pericardial effusion auxiliary drainage device comprises a puncture needle and a liquid storage tank, an upper part of an outer side wall of the puncture needle is provided with a connecting handle, besides, a needle body of the puncture needle is provided with a liquid inlet inner chamber and a liquid outlet inner chamber, a top end port of the liquid inlet inner chamber communicates with a liquid inlet connection pipe and a top end port of the liquid outlet inner chamber port communicates with a liquid outlet connection pipe; the other end of the liquid inlet connection pipe communicates with a liquid inlet pipeline, the otherend of the liquid outlet connection pipe communicates with a Y-shaped pipeline, the other ends of the Y-shaped pipeline respectively communicate with a liquid guiding pipe and an air guiding pipe, and inner chambers of the Y-shaped pipeline and liquid guiding pipe are respectively provided with a one-way valve; and the other end of the liquid guiding pipe communicates with a connecting pipe of the liquid storage tank, and besides, the other end of the air guiding pipe communicates with a suction cylinder. The pericardial effusion auxiliary drainage device is simple in structure and simple inoperation, can input physiological saline into pericardia of patients through the device after effusion is extracted from the patients, and has strong practicability and extremely excellent market promotion value.
Owner:刘娟
Pericardial effusion constant-pressure drainage device for cardiology department nursing
ActiveCN112451761AStable negative pressureReach intelligent warningMedical devicesAlarmsNursing carePericardium
The invention relates to the technical field of cardiology department nursing, and discloses a pericardial effusion constant-pressure drainage device for cardiology department nursing. The device comprises a drainage device main body, an isolation layer is fixedly arranged inside the drainage device main body, an air bag is fixedly arranged inside the drainage device main body, a heating chamber is fixedly arranged inside the air bag, and the bottom of the air bag is fixedly connected with an air guide pipe. Air in the air bag is heated through the heating chamber in the air bag, the air is continuously heated and can leave through the air guide pipe at the top of the air bag, a sliding rod in the air guide pipe can be jacked to vertically move upwards along with rising of the air, a valveblock in a valve groove vertically moves upwards to enable the air guide pipe to communicate, air voids are generated inside the air bag to attract air at the bottom of the isolation layer, negativepressure is generated at the bottom of the isolation layer, pericardial effusion is continuously attracted through a drainage tube, and the effect of maintaining the drainage device main body to generate stable negative pressure is achieved.
Owner:JILIN UNIV FIRST HOSPITAL
Parental human lung adenocarcinoma cell line with high potential of bone metastasis
InactiveCN101717752BRaise the level of basic researchImprove the level of clinical diagnosis and treatmentTissue cultureLymphatic SpreadTherapeutic effect
The invention belongs to the field of micro-organic zooblast system. The invention adopts pericardial effusion of human lung adenocarcinoma patients as a material for building the system and establishes a parental human lung adenocarcinoma cell line with high potential of bone metastasis through cell cultivation, which is called CPA-Y1; and the preservation number of the parental human lung adenocarcinoma cell line is CGMCC No.2521. The established cell line can provide reference data for carrying out early diagnose on human lung adenocarcinoma bone metastases; relevant gene chip technology can be further established; and treatment effect of various medicaments comprising chemical medicaments, biological medicaments, immune medicaments, Chinese medicaments, radioactive medicaments and the like can be evaluated and researched. The parental human lung adenocarcinoma cell line provides a technological platform for searching and diagnosing human lung adenocarcinoma bone metastases and systematically studying multiple lung cancer metastasis. Meanwhile, the parental human lung adenocarcinoma cell line can be used for further analyzing functional genome related to lung cancer bone metastasis and genes related to bone metastasis to provide an effective molecular detection method for early diagnosis and evaluation of treatment effect of bone metastasis.
Owner:SHANGHAI CHEST HOSPITAL
Pericardial effusion extraction device for emergency department
InactiveCN112891645AGood puncture stabilityNo tilting and shaking phenomenonSuction devicesPericardiumBiomedical engineering
The invention relates to the technical field of medical instruments, in particular to a pericardial effusion extraction device for the emergency department. The pericardial effusion extraction device comprises a base, a positioning mechanism and a suction mechanism; a shell is rotatably arranged on the upper end surface of the base, a shell inner cavity is limited in the shell, and a fixed inner plate is fixedly arranged on a center line of the bottom surface of the shell inner cavity in the front-back direction; the positioning mechanism comprises a rotating outer shaft rotationally arranged on the position, close to the upper portion, of the front end face of the base; and the suction mechanism comprises a first fixed cylinder fixedly connected to the upper end surface of the fixed inner plate. The problems that in the pericardial effusion extraction process, a puncture needle is not fixed, stability is poor, the replacing time of an extraction tube is long in the effusion extraction process, and consequently, the life safety of a patient is affected are solved.
Owner:王丰华
Traditional Chinese medicine composition for restoring hydropericardium and preparation method of traditional Chinese medicine composition
InactiveCN107320635APromote circulationImprove digestive systemHydroxy compound active ingredientsInanimate material medical ingredientsDiseaseErigeron
The invention belongs to the technical field of cardiology treatment, and in particular relates to a traditional Chinese medicine composition for recovering pericardial effusion and a preparation method thereof. Wherein the medicine for internal use is composed of the following components by mass: 4-6 parts of Hedyotis diffusa, 3-5 parts of Scutellaria barbata, 3-5 parts of Hedyotis diffusa, 3-5 parts of Cuiyucao, 6-6 parts of soybean 8 parts, 4‑6 parts star anise, 4‑6 parts Andrographis paniculata, 3‑5 parts hydra, 3‑5 parts purslane, 1‑2 parts Arthrophyllum, 4‑6 parts Burnet, Gynostemma 3 ‑5 parts, 4‑6 parts of Atractylodes Rhizome, 3‑5 parts of Baishouwu, 3‑5 parts of keel; the medicine for external use is composed of the following components in parts by mass: 4‑6 parts of Rhizoma Imperatae, 4‑6 parts of Radix Isatidis, 3-5 parts of Jincao, 3-5 parts of Venus Grass, 4-6 parts of Moutan Bark, 3-5 parts of Menthol, 4-6 parts of Erigeron breviscapus, 4-6 parts of Thyme, 5-8 parts of Angelica, 5 parts of Magnolia officinalis ‑8 servings. The invention uses oral Chinese medicinal preparations to astringe wounds to promote wound healing, and at the same time utilizes externally applied medicines to introduce therapeutic medicinal liquids to promote disease recovery and achieve good curative effect.
Owner:QINGDAO CENT HOSPITAL
a pericardial drainage tube
ActiveCN110124181BEasy to fixNot easy to slide outStentsBalloon catheterPericardial drainageCatheter
Owner:JIANGSU PROVINCE HOSPITAL THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIV
Pericardial drainage tube
The invention provides a pericardial drainage tube, which comprises a tube body, a side hole, an air bag and an inflation pipe diameter; the tube body comprises a head end and a tail end, the head endis an elastically curled ring pigtail shape, and the tail end comprises a drainage nozzle and an inflation nozzle, the drainage nozzle communicates with the inside of the tube body; the air bag is disposed on the outer side wall of the tube body, the side hole is opened on the tube wall of the tube body and communicates with the inside of the tube body, and the inflation tube diameter is disposedinside the tube wall of the tube body, and the inflation tube diameter is communicated with the air bag and the inflation nozzle. The pericardial drainage tube is specifically for the drainage problem of pericardial effusion, and the head end is the elastically curled ring pigtail shape, which is beneficial to the fixation of the pericardial drainage tube in the patient body and the drainage of an effusion. With the airbag structure, the space around the pericardial drainage tube can solve the clogging problem of the drainage tube to a certain extent, a fixing function is provided, and the point contact between the catheter air bag and the heart can reduce the onset of arrhythmia and the onset of pain due to heart stimulation of the conduit itself to the patient.
Owner:JIANGSU PROVINCE HOSPITAL THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIV
Drainage guiding device for department of cardiology
InactiveCN113694267AMeet the requirements for pericardial effusion extractionGuaranteed cycle withdrawalSurgeryVaccination/ovulation diagnosticsPericardiumBiomedical engineering
The invention relates to a drainage guiding device for the department of cardiology. The problem that in the prior art, equipment with the quantitative liquid taking function and the periodic needle withdrawing function lacks is effectively solved. According to the technical scheme, the drainage guiding device comprises: a shell and a liquid extraction cavity, wherein the liquid extraction cavity is detachably connected to the upper end of the shell; a bearing ring, wherein a plurality of vacuum liquid taking pipes are detachably mounted on the bearing ring; an injection head, wherein one end of the injection head is communicated with the liquid extraction cavity, and the other end of the injection head can be inserted into the vacuum liquid extraction pipe; and a piston rod which is controlled by a control structure arranged in the shell, wherein the control structure is internally provided with the following control steps of a piston long process step, a piston short process step, a bearing ring stepping step and an injection head intermittent lifting step. The drainage guiding device is simple in structure and convenient to operate, can automatically extract a pericardial effusion sample, has the functions of periodic needle withdrawing and quantitative effusion extraction, reduces the difficulty of pericardial effusion extraction, and is high in practicability.
Owner:娄雪锋
Drainage tube device
PendingCN111701094ADrainage continuesGuaranteed patencyCatheterIntravenous devicesOuter CannulaDrainage tubes
The invention relates to the technical field of medical devices, in particular to a drainage tube device. The drainage tube device comprises a puncture needle, a guide wire, an injector and a drainagetube and also comprises a negative pressure drainage device used for sucking a liquid in the drainage tube to flow, an inner sleeve used for stopping bleeding and washing the drainage tube to guarantee smoothness of the drainage tube as well as an outer sleeve used for allowing the guide wire to penetrate through for drainage, wherein the drainage tube is a double-layer tube and comprises an inner tube and an outer tube. The special pericardial effusion drainage device is designed, the smoothness of the drainage tube can be guaranteed by means of a larger cavity of the drainage tube, and thecircular design of the tail end of the drainage tube can make the drainage tube indwell in a body without stabbing heart tissue; a hydrophilic coating is designed on the outer wall of the tube, so that the drainage tube is more easily sent into a pericardial cavity; and by means of the mated negative pressure drainage device, the outward mobilization dynamic of the drainage tube can be kept, and an effusion can flow outwards continuously.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV
Traditional Chinese medicine for treating heart diseases
InactiveCN104027640AEasy to useSignificant effectCardiovascular disorderPlant ingredientsDiseaseCoronary heart disease
The invention relates to a traditional Chinese medicine for treating heart diseases, belonging to the herbal prescription, and in particular relates to a traditional Chinese medicine for treating heart related diseases, which is composed of the following bulk drugs: 22-28 g of rhodobryum giganteum par, 17-23 g of adiantum capillus-veneris, 22-28 g of sheargrass, 17-23 g of polygonum multiflorum and 8-12 g of lemongrass. Based on the medicine of Yi nationality, the traditional Chinese medicine for treating heart diseases disclosed by the invention is little in drug use amount, lower in cost and reasonable in drug compatibility and is applied to treating rheumatic heart diseases, myocardial premature beat, pericardial effusion, myocardial infarction, myocardial ischemia, cardiovascular and cerebrovascular diseases and pulmonary heart disease; and in addition, the treatment effect is obvious.
Owner:杨兴贵
Medicine combination for treating pericardial effusion and preventing complications
InactiveCN106166148AAvoid serious complicationsSoothe the moodAntibacterial agentsAntipyreticDiseaseApigenin
The invention discloses a medicine combination for treating pericardial effusion and preventing complications. The medicine combination for treating the pericardial effusion and preventing the complications comprises 4-isoniazid, ofloxacin, apigenin, ilexisaponin, ursolic acid, scopoletin, ergosterin, aesculetin, oleanolic acid, mycose, melitose, oridonin, vitamin B2, vitamin C, fillers, adhesives, disintegrating agents and lubricants. The medicine combination is used for treating the pericardial effusion, inflammation is controlled, metabolism is regulated by the aid of components for stopping pain, regulating qi, dispersing blood stasis, dredging collaterals and resisting viruses and tumors, symptoms of the pericardial effusion can be controlled, and diseases causing the pericardial effusion and the complications caused by the pericardial effusion can be relieved.
Owner:王巧玲
Traditional Chinese medicine composition with anti-inflammation sterilization drainage functions and preparation method of composition
InactiveCN107126467AAnti-inflammatoryEasy dischargeOrganic active ingredientsNervous disorderSenna LeavesAdjuvant
The invention discloses a traditional Chinese medicine composition with anti-inflammation sterilization drainage functions. The traditional Chinese medicine composition comprises, by weight, 20-40 parts of arbor, 10-20 parts of Yangxian, 10-20 parts of cherry-apple tree seeds, 20-30 parts of wax trees, 20-30 parts of senna leaves, 5-10 parts of Japanese fleecceflower rhizome, 5-10 parts of common scouring rush herb, 5-15 parts of dasystyle honeysuckle immature flowers and 30-50 parts of white sugar. The arbor, the Yangxian, the cherry-apple tree seeds and the wax trees serve as a monarch medicine, the Japanese fleecceflower rhizome, the common scouring rush herb, the dasystyle honeysuckle immature flowers and the white sugar serve as minister medicine, and the senna leaves serve as adjuvant medicine. Inflammation of an affected part can be effectively removed, excessive moisture in a body is discharged, traditional Chinese medicine components are repeatedly extracted and filtered, effective components in traditional Chinese medicines sufficiently release, and the traditional Chinese medicine composition has remarkable effect on symptoms in bodies such as cirrhotic ascites, pericardial effusion, pleural effusion, hydrothorax and hydrocephalus.
Owner:陈爱荣
Apparatus and methods for noninvasive monitoring of cancerous cells
InactiveCN106102561AImprove the quality of lifeReduce needWound drainsSurgeryAscitesPericardial effusion
A system for noninvasively monitoring cancerous cells within bodily fluid accumulated due to ascites, pleural effusion or pericardial effusion is provided including an implantable pump having control circuitry; a charging and communication system configured to periodically charge and communicate with the implantable pump to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable pump and charging and communication system. The implantable pump is configured to move fluid containing cancerous cells from a body cavity to the bladder such that the fluid may be excreted during urination, collected and analyzed with an analysis station to assess progress of the cancer or efficacy of a cancer treatment program.
Owner:SEQUANA MEDICAL
Compound egg yolk antibody for preventing and treating pericardial effusion-hepatitis syndrome of chicken, and preparation method of compound egg yolk antibody
ActiveCN106729707ALow toxicityAvoid damageDispersion deliveryAntiviralsDiseaseRadix Astragali seu Hedysari
The invention provides a compound egg yolk antibody for preventing and treating pericardial effusion-hepatitis syndrome of chickens, and a preparation method of the compound egg yolk antibody. The compound egg yolk antibody is prepared from the following raw materials: 10-50g of traditional Chinese medicine extracts, 400-2000ml of an adenovirus egg yolk antibody and 2-10g of sodium benzoate. According to the compound egg yolk antibody for preventing and treating the pericardial effusion-hepatitis syndrome of the chicken, the traditional Chinese medicine extracts such as radix aconiti lateralis praeparata, rhizoma coptidis, radix astragali seu hedysari, liquorice root, herba pogostemonis, herba eupatorii, rhizoma atractylodis, cortex magnoliae officinalis, fructus amomi rotundus, and the like are added on the basis of the prepared adenovirus egg yolk antibody, so that the compound egg yolk antibody is high in valence, can remarkably repair the myocardial damage of the chickens with the disease, promotes the absorption of pericardial fluid, improves immunity of the organism, prevents secondary infection of the organism, and obviously reduces the death rate of the chickens with the disease.
Owner:TIANJIN ZHONGSHENG TIAOZHAN BIOTECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com